Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Beliën, J.A.M.
Right arrow Articles by Baak, J.P.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beliën, J.A.M.
Right arrow Articles by Baak, J.P.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells

J.A.M. Beliën, M.P. Copper 1, B.J.M. Braakhuis 1, G.B. Snow 1 and J.P.A. Baak 2

Departments of Pathology Free University Hospital PO Box 7057, 1007 MB, Amsterdam, The Netherlands
1Otolaryngologyl/ Head and Neck Surgery Free University Hospital PO Box 7057, 1007 MB, Amsterdam, The Netherlands

2To whom correspondence should be addressed

The proportion of exfoliated buccal mucosal cells with micronuclei gives the opportunity to assess sensitivity to {gamma}- radiation and genotoxic compounds and In addition to monitor the effectiveness of cancer intervention strategies. So far, results on counting micronuclel in various publications are difficult to compare because of differences in methods used, especially with regard to microscopical magnification used and number of cells counted. The aims of this study were (i) to define a protocol for counting micronuclei; (ii) to assess the feasibility of manually counting micronuclel; and (iii) the assessment of inter- and intra-patient variability of the number of micronuclel. We propose the definition of a strict protocol on counting micronuclei, with regard to cytological preparation, definition of micronuclei, instrumentation, sampling of cells in a cytological specimen and sample size. Such a strict protocol is a prerequisite for counting micronuclei in exfoliated cells to get a reproducible and sensitive indicator of exposure and for cancer risk. Although the Inter- and intra-observer reproducibility of counting mlcronuclei per 1000 cells using such a protocol is well, we show that the variability among 10 assessments of micronuclel per 1000 cells taken sequentially from a sample size of 10 000 nuclei of the same specimen can be enormous (coefficients of variation varied in seven individuals studied between 42.1 and 102.9%). Based on the observed low frequencies varying from 1.2 to 5.2 micronuclei per 1000 cells and the variation found, we condude that at least 10 000 exfoliated cells should be screened to monitor a significant reduction of 50% in the number of micronuclei (for a patient with an initial frequency in the micronuclei frequency range given). Since it takes ~7 h to evaluate this number of cells, it is also concluded that counting of micronuclel requires automation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Dentomaxillofac RadiolHome page
D A Ribeiro, G de Oliveira, G. de Castro, and F Angelieri
Cytogenetic biomonitoring in patients exposed to dental X-rays: comparison between adults and children
Dentomaxillofac. Radiol., October 1, 2008; 37(7): 404 - 407.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
P. Thomas and M. Fenech
Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease
Mutagenesis, January 1, 2008; 23(1): 57 - 65.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
P. Thomas, J. Hecker, J. Faunt, and M. Fenech
Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease
Mutagenesis, November 1, 2007; 22(6): 371 - 379.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
M. Fenech, C. Bolognesi, M. Kirsch-Volders, S. Bonassi, E. Zeiger, S. Knasmuller, and N. Holland
Harmonisation of the micronucleus assay in human buccal cells--a Human Micronucleus (HUMN) project (www.humn.org) initiative commencing in 2007
Mutagenesis, January 1, 2007; 22(1): 3 - 4.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. J. Van Schooten, A. Besarati Nia, S. De Flora, F. D'Agostini, A. Izzotti, A. Camoirano, A. J. M. Balm, J. W. Dallinga, A. Bast, G. R. M. M. Haenen, et al.
Effects of Oral Administration of N-Acetyl-L-cysteine: A Multi-Biomarker Study in Smokers
Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 167 - 175.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. K. Nersesyan
Re: Rajeswari,N., Ahuja,Y.R., Malani,U., Chandrashekar,S., Balakrishna,N., Rao,K.V. and Khar,A. (2000) Risk assessment in the first degree female relatives of breast cancer patients using the alkaline Comet assay. Carcinogenesis, 21, 557-561
Carcinogenesis, April 1, 2001; 22(4): 679 - 679.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.